Literature DB >> 31882465

Efficiency of Gastrointestinal Cancer Detection by Nematode-NOSE (N-NOSE).

Hirotake Kusumoto1, Kotaro Tashiro1, Syunji Shimaoka1, Koichiro Tsukasa1, Yukiko Baba1, Saori Furukawa1, Junichiro Furukawa1, Toru Niihara2, Takaaki Hirotsu3,4,5, Takayuki Uozumi6.   

Abstract

BACKGROUND/AIM: Early detection of gastrointestinal cancer may reduce mortality. Recently, Caenorhabditis elegans has been reported to be capable of differentiating patients with cancers from healthy persons by the smell of urine. This novel technique using C. elegans olfaction has been named as Nematode-NOSE (N-NOSE).
MATERIALS AND METHODS: We collected 180 urine samples from patients with gastrointestinal cancer and 76 samples from healthy subjects. N-NOSE test was performed using these samples and N-NOSE index was obtained. Quantification of the olfactory behavior of C. elegans was performed as established in past studies. By receiver operating characteristic (ROC) analysis, we examined the diagnostic capability of N-NOSE.
RESULTS: ROC analysis revealed that N-NOSE showed an area under the curve value of more than 0.80, even in early-stage cancers.
CONCLUSION: C. elegans olfaction enabled the detection of gastrointestinal cancers from urine with high sensitivity, which can provide the basis for the development of N-NOSE as a gastrointestinal cancer screening test. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  C. elegans; Gastrointestinal cancer; N-NOSE; early-stage; screening tests

Mesh:

Substances:

Year:  2020        PMID: 31882465      PMCID: PMC6984105          DOI: 10.21873/invivo.11747

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  23 in total

Review 1.  Phases of biomarker development for early detection of cancer.

Authors:  M S Pepe; R Etzioni; Z Feng; J D Potter; M L Thompson; M Thornquist; M Winget; Y Yasui
Journal:  J Natl Cancer Inst       Date:  2001-07-18       Impact factor: 13.506

2.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

Review 3.  Contrasting US and European approaches to colorectal cancer screening: which is best?

Authors:  Geir Hoff; Jason A Dominitz
Journal:  Gut       Date:  2010-03       Impact factor: 23.059

Review 4.  The scent of disease: volatile organic compounds of the human body related to disease and disorder.

Authors:  Mika Shirasu; Kazushige Touhara
Journal:  J Biochem       Date:  2011-07-19       Impact factor: 3.387

5.  Screening of odor-receptor pairs in Caenorhabditis elegans reveals different receptors for high and low odor concentrations.

Authors:  Gun Taniguchi; Takayuki Uozumi; Keisuke Kiriyama; Tomoko Kamizaki; Takaaki Hirotsu
Journal:  Sci Signal       Date:  2014-04-29       Impact factor: 8.192

Review 6.  Esophageal cancer: Risk factors, genetic association, and treatment.

Authors:  Fang-Liang Huang; Sheng-Jie Yu
Journal:  Asian J Surg       Date:  2016-12-13       Impact factor: 2.767

7.  Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial.

Authors:  Esther M Stoop; Margriet C de Haan; Thomas R de Wijkerslooth; Patrick M Bossuyt; Marjolein van Ballegooijen; C Yung Nio; Marc J van de Vijver; Katharina Biermann; Maarten Thomeer; Monique E van Leerdam; Paul Fockens; Jaap Stoker; Ernst J Kuipers; Evelien Dekker
Journal:  Lancet Oncol       Date:  2011-11-15       Impact factor: 41.316

8.  Urinary volatile compounds as biomarkers for lung cancer.

Authors:  Yosuke Hanai; Ken Shimono; Koichi Matsumura; Anil Vachani; Steven Albelda; Kunio Yamazaki; Gary K Beauchamp; Hiroaki Oka
Journal:  Biosci Biotechnol Biochem       Date:  2012-04-07       Impact factor: 2.043

9.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

Authors:  P GOLD; S O FREEDMAN
Journal:  J Exp Med       Date:  1965-03-01       Impact factor: 14.307

10.  A highly accurate inclusive cancer screening test using Caenorhabditis elegans scent detection.

Authors:  Takaaki Hirotsu; Hideto Sonoda; Takayuki Uozumi; Yoshiaki Shinden; Koshi Mimori; Yoshihiko Maehara; Naoko Ueda; Masayuki Hamakawa
Journal:  PLoS One       Date:  2015-03-11       Impact factor: 3.240

View more
  4 in total

Review 1.  Nematode-Applied Technology for Human Tumor Microenvironment Research and Development.

Authors:  Eric di Luccio; Satoru Kaifuchi; Nobuaki Kondo; Ryota Chijimatsu; Andrea Vecchione; Takaaki Hirotsu; Hideshi Ishii
Journal:  Curr Issues Mol Biol       Date:  2022-02-21       Impact factor: 2.976

2.  A new detection method for canine and feline cancer using the olfactory system of nematodes.

Authors:  Toshimi Sugimoto; Yozo Okuda; Ayaka Shima; Natsuko Sugiura; Nobuaki Kondo; Genki Ishihara; Takaaki Hirotsu; Eric di Luccio
Journal:  Biochem Biophys Rep       Date:  2022-09-05

3.  A Caenorhabditis elegans behavioral assay distinguishes early stage prostate cancer patient urine from controls.

Authors:  Morgan Thompson; Noemi Sarabia Feria; Ally Yoshioka; Eugene Tu; Fehmi Civitci; Suzanne Estes; Josiah T Wagner
Journal:  Biol Open       Date:  2021-03-26       Impact factor: 2.422

Review 4.  State-of-the-Art Technology of Model Organisms for Current Human Medicine.

Authors:  Masamitsu Konno; Ayumu Asai; Toru Kitagawa; Masami Yabumoto; Ken Ofusa; Takahiro Arai; Takaaki Hirotsu; Yuichiro Doki; Hidetoshi Eguchi; Hideshi Ishii
Journal:  Diagnostics (Basel)       Date:  2020-06-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.